P53 Codon 72 polymorphisms: A case-control study of gastric cancer and potential interactions

Cancer Letters

Volumn 238, Issue 2, 2006, Pages 210-223

  Sul, James ^a   Yu, Guo Pei ^b   Lu, Qing Yi ^c   Lu, Ming Lan ^d   Setiawan, Veronica Wendy ^e   Wang, Ming Rong ^f   Guo, Chun Hua ^f   Yu, Shun Zhang ^g   Mu, Lina ^g   Cai, Lin ^h   Kurtz, Robert C ^d   Zhang, Zuo Feng ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NEW YORK EYE AND EAR INFIRMARY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f Yangzhong County Anti Epidemic Station   (China)

^g FUDAN UNIVERSITY   (China)

^h Fijian Medical University   (China)

Author keywords

Gastric cancer; gene environment interaction; p53 codon 72 polymorphism

Indexed keywords

ALCOHOL; ASCORBIC ACID; FAT; PROTEIN P53; SODIUM;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CALORIC INTAKE; CANCER CENTER; CANCER RISK; CASE CONTROL STUDY; CODON; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATION; ENVIRONMENTAL FACTOR; FAT INTAKE; FEMALE; FIBER; GENE INTERACTION; GENETIC POLYMORPHISM; HELICOBACTER PYLORI; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE; SMOKING; SODIUM INTAKE; STATISTICAL SIGNIFICANCE; STOMACH CANCER; VITAMIN INTAKE;

ADULT; AGED; ASCORBIC ACID; CASE-CONTROL STUDIES; CODON; ENERGY INTAKE; FEMALE; GENES, P53; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS; STOMACH NEOPLASMS;

HELICOBACTER PYLORI;

EID: 33745109882     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.07.004     Document Type: Article

References (37)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 94 (2001) 153-156
2. Devesa S.S., and Fraumeni Jr. F. J. Natl. Cancer Inst. 91 (1999) 747-749
3. Cancer Facts & Figures 2003.
4. Tahara E. Molecular mechanism of stomach carcinogenesis. J. Cancer Res. Clin. Oncol. 119 (1993) 265-272
5. Neugut A.I., Hayek M., and Howe G. Epidemiology of gastric cancer. Semin. Oncol. 23 (1996) 281-291
6. Mayne S.T., and Navarro S.A. Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans. J. Nutr. 132 (2002) 3467S-3470S
7. Chen M.J., Chiou Y.Y., Wu D.C., and Wu S.L. Lifestyle habits and gastric cancer in a hospital-based case-control study in Taiwan. Am. J. Gastroenterol 95 (2000) 3242-3249
8. Palli D., Russo A., and Decarli A. Dietary patterns, nutrient intake and gastric cancer in a high-risk area of Italy. Cancer Causes Control 12 (2001) 163-172
9. Terry P., Lagergren J., Ye W., Wolk A., and Nyren O. Inverse association between intake of cereal fiber and risk of gastric cardia cancer. Gastroenterology 120 (2001) 387-391
10. Hohenberger P., and Gretschel S. Gastric cancer. Lancet 362 (2003) 305-315
11. Kelley J.R., and Duggan J.M. Gastric cancer epidemiology and risk factors. J. Clin. Epidemiol. 56 (2003) 1-9
12. Setiawan V.W., Zhang Z.F., Yu G.P., Lu Q.Y., Li Y.L., Lu M.L., et al. Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int. J. Cancer 92 (2001) 600-604
13. Levine A.J. The p53 tumour suppressor gene and product. Cancer. Surv. 12 (1992) 59-79
14. Gabbert H.E., Muller W., Schneiders A., Meier S., and Hommel G. The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma. Cancer 76 (1995) 720-726
15. Matozaki T., Sakamoto C., Suzuki T., Matsuda K., Uchida T., Nakano O., et al. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells. Cancer Res. 52 (1992) 4335-4341
16. Shepherd T., Tolbert D., Benedetti J., Macdonald J., Stemmermann G., Wiest J., et al. Alterations in exon 4 of the p53 gene in gastric carcinoma. Gastroenterology 118 (2000) 1039-1044
17. Thomas M., Kalita A., Labrecque S., Pim D., Banks L., and Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol. Cell. Biol. 19 (1999) 1092-1100
18. Wang Y.C., Lee H.S., Chen S.K., Chang Y.Y., and Chen Y. Prognostic significance of p53 codon 72 polymorphism in lung carcinomas. Eur. J. Cancer 35 (1999) 226-230
19. Birgander R., Sjalander A., Zhou Z., Fan C., Beckman L., and Beckman G. p53 polymorphisms and haplotypes in nasopharyngeal cancer. Hum. Hered. 46 (1996) 49-54
20. Kawajiri K., Nakachi K., Imai K., Watanabe J., and Hayashi S. Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis 14 (1993) 1085-1089
21. Jin X., Wu X., Roth J.A., Amos C.I., King T.M., Branch C., et al. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis 16 (1995) 2205-2208
22. Papadakis E.N., Dokianakis D.N., and Spandidos A. p53 codon 72 polymorphism as a risk factor in the development of breast cancer. Mol. Cell Biol. Res. Commun. 3 (2000) 389-392
23. Sjalander A., Birgander R., Hallmans G., Cajander S., Lenner P., Athlin L., et al. p53 polymorphisms and haplotypes in breast cancer. Carcinogenesis 17 (1996) 1313-1316
24. Dokianakis D.N., and Spandidos A. P53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer. Mol. Cell Biol. Res. Commun. 3 (2000) 111-114
25. Storey A., Thomas M., Kalita A., Harwood C., Gardiol D., Mantovani F., et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393 (1998) 229-234
26. Hiyama T., Tanaka S., Kitadai Y., Ito M., Sumii M., Yoshihara M., et al. p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis. Int. J. Cancer 100 (2002) 304-308
27. Zhang Z.W., Newcomb P., Hollowood A., Feakins R., Moorghen M., Storey A., et al. Age-associated increase of codon 72 arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma. Clin. Cancer Res. 9 (2003) 2151-2156
28. Lagergren J., Bergstrom R., and Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann. Intern. Med. 130 (1999) 883-890
29. Thompson H.J., Zhu Z., and Jiang W. Protection against cancer by energy restriction: all experimental approaches are not equal. J. Nutr. 132 (2002) 1047-1049
30. Jacobs E.J., Connell C.J., McCullough M.L., Chao A., Jonas C.R., Rodriguez C., et al. Vitamin C, vitamin E, and multivitamin supplement use and stomach cancer mortality in the cancer prevention study II cohort. Cancer Epidemiol. Biomarkers Prev. 11 (2002) 35-41
31. You W.C., Zhang L., Gail M.H., Chang Y.S., Liu W.D., Ma J.L., et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J. Natl. Cancer. Inst. 92 (2000) 1607-1612
32. Stahelin H.B., Gey K.F., Eichholzer M., Ludin E., Bernasconi F., Thurneysen J., et al. Plasma antioxidant vitamins and subsequent cancer mortality in the 12-year follow-up of the prospective basel study. Am. J. Epidemiol. 133 (1991) 766-775
33. Correa P., Fontham E.T., Bravo J.C., Bravo L.E., Ruiz B., Zarama G., et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J. Natl. Cancer. Inst. 92 (2000) 1881-1888
34. Drake I.M., Davies M.J., Mapstone N.P., Dixon M.F., Schorah C.J., White K.L., et al. Ascorbic acid may protect against human gastric cancer by scavenging mucosal oxygen radicals. Carcinogenesis 17 (1996) 559-562
35. Sierra R., Chinnock A., Ohshima H., Pignatelli B., Malaveille C., Gamboa C., et al. In vivo nitrosoproline formation and other risk factors in Costa Rican children from high- and low-risk areas for gastric cancer. Cancer Epidemiol. Biomarkers Prev. 2 (1993) 563-568
36. Mannick E.E., Bravo L.E., Zarama G., Realpe J.L., Zhang X.J., Ruiz B., et al. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res. 56 (1996) 3238-3243
37. Zatonski W., Ohshima H., Przewozniak K., Drosik K., Mierzwinska J., Krygier M., et al. Urinary excretion of N-nitrosamino acids and nitrate by inhabitants of high- and low-risk areas for stomach cancer in Poland. Int. J. Cancer 44 (1989) 823-827